The strongest version of this narrative is that OpenAI is responsibly extending a powerful AI tool into a high-stakes domain where speed and accuracy can save lives. By restricting access to vetted organizations, they’re attempting to mitigate the dual-use risks inherent in biological research. The program’s focus on defensive applications—early detection, screening, and preparedness—aligns with public health priorities, and the involvement of government and external experts suggests a commitmen...